Andropause: Coming of age for an old concept?

Current Opinion in Urology

Volumn 11, Issue 6, 2001, Pages 597-601

  Heaton, Jeremy P W ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; INTERLEUKIN 6; SEX HORMONE;

AGING; ANDROGEN THERAPY; ANDROPAUSE; CLIMACTERIUM; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; REPRODUCTION; REVIEW; SURVIVAL;

AGING; CLIMACTERIC; ECONOMICS, PHARMACEUTICAL; HUMANS; MALE; POLITICS; TESTOSTERONE;

EID: 0034767523     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-200111000-00007     Document Type: Review

References (17)

1. Diseases of aging
2. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty
3. The dose-dependent effects of testosterone on sexual function and on muscle mass and function
4. Age related testosterone level changes and male andropause syndrome
5. Hormonal deficiency in elderly males
6. Andropause: Testosterone replacement therapy for aging men
7. Andropause
8. Androgen deficiency in aging men: Role of testosterone replacement therapy
9. Andropause, testosterone therapy, and quality of life in aging men
10. Andropause: A misnomer for a true clinical entity
11. Andropause: Hormone replacement therapy in the ageing male
12. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men
13. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men
14. Effects of transdermal application of DHEA on the levels of steroids, gonadotropins and lipids in men
15. Andropause: Is it time for the geriatrician to treat it?
16. Maturitas, the European menopause journal, becomes 'official journal of the European Menopause and Andropause Society'
17. Economic cost of male erectile dysfunction using a decision analytic model for a hypothetical managed-care plan of 100,000 members